Ortivus

Ortivus EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Ortivus (ORTI B.ST) as of Nov 4, 2026 is -19.81 M SEK. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -17.45 M SEK — a change of 13.52% (lower).

EBITDA

-19.81 MSEK

YoY

13.52%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Ortivus is 2025 -19.81 M SEK. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Ortivus was 2024 -17.45 M SEK. It decreases by 13.52% lower compared to the previous year.

The Ortivus EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
-12.76 M SEK
Jan 1, 2019
-14.23 M SEK
Jan 1, 2020
12.77 M SEK
Jan 1, 2021
9.65 M SEK
Jan 1, 2022
6.76 M SEK
Jan 1, 2023
-15.34 M SEK
Jan 1, 2024
-17.45 M SEK
Jan 1, 2025
-19.81 M SEK
The Ortivus EBITDA history
YEAREBITDAYoY
-19.81 MSEK+13.52%
-17.45 MSEK+13.71%
-15.34 MSEK-327.02%
6.76 MSEK-29.98%
9.65 MSEK-24.40%
12.77 MSEK-189.71%
-14.23 MSEK+11.55%
-12.76 MSEK+195.67%
-4.32 MSEK-15.59%
-5.11 MSEK-7.68%
-5.54 MSEK-431.95%
1.67 MSEK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ortivus Stock analysis

What does Ortivus do? Ortivus AB develops and sells clinical devices and systems, including MobiMed Smart, a decision support system for ambulance personnel to handle documentation, monitoring, and structured prehospital care. CoroNet is a mobile surveillance solution enabling patients to move freely under medical supervision while providing healthcare professionals with real-time monitoring data. The company offers additional services like support, implementation, training, and consulting. Its primary customers are ambulance services and emergency departments. Ortivus AB generates revenue through the sale of MobiMed Smart and CoroNet systems, along with associated services. Ambulance services and emergency departments purchase these products to improve prehospital care documentation and patient monitoring. The decision support system MobiMed Smart streamlines ambulance operations, while CoroNet enhances patient supervision in healthcare settings, addressing key needs for efficient medical response and care management. The company's revenue model relies on direct sales of its clinical systems and supplementary services to healthcare providers. MobiMed Smart targets ambulance personnel for prehospital care documentation, and CoroNet serves healthcare professionals needing mobile patient monitoring. These products are tailored to the specific operational requirements of ambulance services and emergency departments, ensuring alignment with their workflows and care standards. Ortivus is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ortivus stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Ortivus is -19.81 M SEK in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Ortivus changed from -17.45 M SEK to -19.81 M SEK, representing a 13.52% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Ortivus since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s SEK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Ortivus historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Ortivus

All Key Metrics — Ortivus